|
|
| |
|
First responder in a pandemic but also first to market with seasonal vaccine
|
|
|
|
Benefits of Virus-Like Particles
|
 
- Best compromise between safety and efficacy i.e. not infectious but highly immunogenic
- Provide protection at lower doses
- Much cheaper
- Controlling IP
|
|
|
